A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008254/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess ALD403 in the prevention of migraine headache in
frequent episodic migraineurs.
提供机构：
Vivli
创建时间：
2022-07-15
